| Model Number |
305C25 |
| Medical Device Problem Code |
Insufficient Device Problem Information (3190)
|
| Health Effect - Clinical Codes |
Calcium Deposits/Calcification (1758); Thrombosis/Thrombus (4440)
|
| Date of Event |
10/03/2024
|
|
Type of Reportable Event
|
Serious Injury
|
|
Additional Manufacturer Narrative
|
|
Medtronic submits this report to comply with fda regulations 21 cfr parts 4 and 803.Medtronic has made reasonable efforts to provide as much relevant information as is available to the company as of the submission date of this report.This report does not constitute an admission or a conclusion by fda, medtronic, or its employees that the device, medtronic, or its employee caused or contributed to the event described in the report.Any required fields that are unpopulated are blank because the information is currently unknown or unavailable.Medtronic will submit a supplemental report if additional relevant information becomes known.
|
| |
|
Event or Problem Description
|
|
Medtronic received information that 14 years and 11 months post implant of this aortic bioprosthetic valve, the patient is being eva luated for a transcatheter valve-in-valve replacement.The reason for evaluation was not reported.It was noted during evaluation that calcium could be seen in the proximal left coronary artery and abdominal aorta.A possible pannus or thrombus could be present as well.No intervention or adverse patient effects were reported.
|
| |
|
Additional Manufacturer Narrative
|
|
Medtronic submits this report to comply with fda regulations 21 cfr parts 4 and 803.Medtronic has made reasonable efforts to provide as much relevant information as is available to the company as of the submission date of this report.This report does not constitute an admission or a conclusion by fda, medtronic, or its employees that the device, medtronic, or its employee caused or contributed to the event described in the report.Any required fields that are unpopulated are blank because the information is currently unknown or unavailable.Medtronic will submit a supplemental report if additional relevant information becomes known.
|
| |
|
Event or Problem Description
|
|
Medtronic received additional information that 6 weeks later, a transcatheter valve was implanted valve-in-valve.The reason for int ervention was reported as "failed surgical aortic valve".No additional adverse patient effects were reported.
|
| |
|
Search Alerts/Recalls
|